Current Oncology Reports

, Volume 7, Issue 2, pp 145–153 | Cite as

Prevention of head and neck cancer

  • Terry A. Day
  • Angela Chi
  • Brad Neville
  • James R. Hebert
Article

Abstract

In the vast majority of cases, head and neck cancer is a preventable disease. The relationship between tobacco and alcohol and these cancers is well established. Despite efforts aimed at reduction of risk factor exposure and early detection methods, head and neck cancer remains one of the more common cancers worldwide. Recent advances in molecular techniques have provided a framework for future targets for early diagnosis and treatment of these malignancies. This review provides a summary of recent developments in primary and secondary prevention of head and neck cancer and innovative strategies aimed at a reduction in incidence and mortality from this disease. The future prevention of head and neck cancer will likely require solutions to the widespread use of tobacco products and innovative diagnostic techniques leading to improvements in overall survival.

Keywords

Neck Cancer Oral Cancer Isotretinoin Neck Squamous Cell Carcinoma Amifostine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Parkin, DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999, 80:827–841.PubMedCrossRefGoogle Scholar
  2. 2.
    Mignogna, MD, Fedele S, and Russo LL: The World Cancer Report and the burden of oral cancer. Eur J Cancer Prev 2004, 13:139–142. A recent review of the worldwide oral cancer problem and the importance of early detection and prevention in controlling the disease. This article highlights the high cost and problems with current research trends in light of oral cancer being one of the most obvious cancers for direct prevention and early detection efforts.PubMedCrossRefGoogle Scholar
  3. 3.
    Cmelak, AJ, Murphy BA, Day T: Combined-modality therapy for locoregionally advanced head and neck cancer. Oncology (Huntingt) 1999, 13(Suppl:5):83–91.Google Scholar
  4. 4.
    Califano J, van der Riet P, Westra W, et al.: Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996, 56:2488–2492.PubMedGoogle Scholar
  5. 5.
    Gleich LL, Salamone FN: Molecular genetics of head and neck cancer. Cancer Control 2002, 9:369–378.PubMedGoogle Scholar
  6. 6.
    Kashiwazaki H, Tonoki H, Tada M, et al.: High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay. Oncogene 1997, 15:2667–2674.PubMedCrossRefGoogle Scholar
  7. 7.
    Meredith SD, Levine PA, Burns JA, et al.: Chromosome 11q13 amplification in head and neck squamous cell carcinoma: association with poor prognosis. Arch Otolaryngol Head Neck Surg 1995, 121:790–794.PubMedGoogle Scholar
  8. 8.
    Michalides RJ, van Veelen NM, Kristel PM, et al.: Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1997, 123:497–502.PubMedGoogle Scholar
  9. 9.
    Sudbó J, Lippman SM, Lee JJ, et al.: The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 2004, 350:1405–1413.PubMedCrossRefGoogle Scholar
  10. 10.
    Miyaguchi, Olofsson MJ, Hellquist HB: Expression of epidermal growth factor receptor in laryngeal dysplasia and carcinoma. Acta Otolaryngol 1990, 110:309–313.PubMedGoogle Scholar
  11. 11.
    Nathan CA, Amirghahri N, Rice C, et al.: Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Laryngoscope 2002, 112:2129–2140.PubMedCrossRefGoogle Scholar
  12. 12.
    Riedel F, Gotte K, Li M, et al.: Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo. Int J Oncol 2003, 23:577–583.PubMedGoogle Scholar
  13. 13.
    Relf M, LeJeune S, Scott PA, et al.: Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997, 57:963–969.PubMedGoogle Scholar
  14. 14.
    Herbst RS, Kim ES, and Harari PM: IMC-C225, an antiepidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer. Expert Opin Biol Ther 2001, 1:719–732.PubMedCrossRefGoogle Scholar
  15. 15.
    Young MR: Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 2004, 53:375–382.PubMedCrossRefGoogle Scholar
  16. 16.
    US Department of Health and Human Services: Oral Health in America: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services. National Institute of Dental and Craniofacial Research; 2000 (NIH).Google Scholar
  17. 17.
    US Department of Health and Human Services: Healthy People 2010 (conference edition, in two volumes). Rockville, MD: US Department of Health and Human Services; 2000. Anyone interested in oral cancer prevention and control in the United States should be aware of current and future goals and efforts developed in the Healthy People 2010 related to oral and oropharyngeal cancer control.Google Scholar
  18. 18.
    Johnson N: Tobacco use and oral cancer: a global perspective. J Dent Educ 2001, 65:328–39.PubMedGoogle Scholar
  19. 19.
    Vineis P, Alavanja M, Buffler P, et al.: Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004, 96:99–106.PubMedCrossRefGoogle Scholar
  20. 20.
    Mashberg A, Boffetta P, Winkelman R, Garfinkel L: Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993, 72:1369–1375.PubMedCrossRefGoogle Scholar
  21. 21.
    Blot WJ, McLaughlin JK, Winn DM, et al.: Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988, 48:3282–3287.PubMedGoogle Scholar
  22. 22.
    Winn DM: Smokeless tobacco and cancer: the epidemiologic evidence. CA Cancer J Clin 1988, 38:236–243.PubMedGoogle Scholar
  23. 23.
    Winn DM, Blot WJ, Shy CM, et al.: Snuff dipping and oral cancer among women in the southern United States. N Engl J Med 1981, 304:745–749.PubMedCrossRefGoogle Scholar
  24. 24.
    Schantz SP, Yu GP: Head and neck cancer incidence trends in young Americans, 1973–1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 2002, 128:268–274.PubMedGoogle Scholar
  25. 25.
    Rosenblatt KA, Daling JR, Chen C, et al.: Marijuana use and risk of oral squamous cell carcinoma. Cancer Res 2004, 64:4049–4054.PubMedCrossRefGoogle Scholar
  26. 26.
    Zhang ZF, Morgenstern H, Spitz MR, et al.: Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 1999, 8:1071–1078.PubMedGoogle Scholar
  27. 27.
    Zhang ZF, Morgenstern H, Spitz MR, et al.: Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2000, 9:1043–1049.PubMedGoogle Scholar
  28. 28.
    Richardson GE, Tucker MA, Venzon DJ, et al.: Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med 1993, 119:383–390.PubMedGoogle Scholar
  29. 29.
    Yu GP, Ostroff JS, Zhang ZF, et al.: Smoking history and cancer patient survival: a hospital cancer registry study. Cancer Detect Prev 1997, 21:497–509.PubMedGoogle Scholar
  30. 30.
    Badger TM, Ronis MJ, Seitz HK., et al.: Alcohol metabolism: role in toxicity and carcinogenesis. Alcohol Clin Exp Res 2003, 27:336–47.PubMedCrossRefGoogle Scholar
  31. 31.
    Viswanathan H, Wilson JA: Alcohol: the neglected risk factor in head and neck cancer. Clin Otolaryngol 2004, 29:295–300.PubMedCrossRefGoogle Scholar
  32. 32.
    Moore S, Johnson N, Pierce A, Wilson D: The epidemiology of lip cancer: a review of global incidence and aetiology. Oral Dis 1999, 5:185–195.PubMedCrossRefGoogle Scholar
  33. 33.
    Levi F, La Vecchia C, Te VC, Franceschi S: Trends in lip cancer incidence in Vaud, Switzerland. Br J Cancer 1993, 68:1012–1013.PubMedGoogle Scholar
  34. 34.
    Shiu MN, Chen TH: Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer. Eur J Cancer Prev 2004, 13:39–45.PubMedCrossRefGoogle Scholar
  35. 35.
    Murti PR, Bhonsle RB, Pindborg JJ, et al.: Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol 1985, 13:340–341.PubMedCrossRefGoogle Scholar
  36. 36.
    Winn DM: Diet and nutrition in the etiology of oral cancer. Am J Clin Nutr 1995, 61:437S-445S.PubMedGoogle Scholar
  37. 37.
    Llewellyn CD, Linklater K, Bell J, et al.: An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol 2004, 40:304–313.PubMedCrossRefGoogle Scholar
  38. 38.
    Gillison ML, Lowy DR: A causal role for human papillomavirus in head and neck cancer. Lancet 2004, 363:1488–1489. Increasing evidence supports the potential role of HPV as an associated factor in the development of certain oral and oropharyngeal cancers.PubMedCrossRefGoogle Scholar
  39. 39.
    Herrero R, Castellsague X, Pawlita M, et al.: Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003, 95:1772–1783.PubMedGoogle Scholar
  40. 40.
    Ha PK, Califano JA: The role of human papillomavirus in oral carcinogenesis. Crit Rev Oral Biol Med 2004, 15:188–196.PubMedGoogle Scholar
  41. 41.
    Dahlstrand H, Dahlgren L, Lindquist D, et al.: Presence of human papillomavirus in tonsillar cancer is a favourable prognostic factor for clinical outcome. Anticancer Res 2004. 24:1829–1835.PubMedGoogle Scholar
  42. 42.
    Sisk EA, Soltys SG, Zhu S, et al.: Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck 2002, 24:841–849.PubMedCrossRefGoogle Scholar
  43. 43.
    Krutchkoff DJ, Cutler L, Laskowski S: Oral lichen planus: the evidence regarding potential malignant transformation. J Oral Pathol 1978, 7:1–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Eisenberg E: Lichen planus and oral cancer: Is there a connection between the two? J Am Dent Assoc 1992, 123:104–108.PubMedGoogle Scholar
  45. 45.
    Yu GP, Zhang ZF, Hsu TC, et al.: Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer. Cancer Lett 1999, 146:93–101.PubMedCrossRefGoogle Scholar
  46. 46.
    Foulkes WD, Brunet JS, Sieh W, et al.: Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. BMJ 1996, 313:716–721.PubMedGoogle Scholar
  47. 47.
    Foulkes WD, Brunet JS, Kowalski LP, et al.: Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study. Int J Cancer 1995, 63:769–773.PubMedCrossRefGoogle Scholar
  48. 48.
    Yu KK, Zanation AM, Moss JR, Yarbrough WG: Familial head and neck cancer: molecular analysis of a new clinical entity. Laryngoscope 2002, 112:1587–1593.PubMedCrossRefGoogle Scholar
  49. 49.
    Yarbrough WG, Aprelikova O, Pei H, et al.: Familial tumor syndrome associated with a germline nonfunctional p16INK4a allele. J Natl Cancer Inst 1996, 88:1489–1491.PubMedCrossRefGoogle Scholar
  50. 50.
    Flaitz CM, Nichols CM, Adler-Storthz K, Hicks MJ: Intraoral squamous cell carcinoma in human immunodeficiency virus infection: a clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995, 80:55–62.PubMedCrossRefGoogle Scholar
  51. 51.
    Barry B, Gehanno P: Squamous cell carcinoma of the ENT organs in the course of the HIV infection. Ann Otolaryngol Chir Cervicofac 1999, 116:149–153.PubMedGoogle Scholar
  52. 52.
    van Zuuren EJ, de Visscher JG, Bouwes Bavinck JN: Carcinoma of the lip in kidney transplant recipients. J Am Acad Dermatol 1998, 38:497–499.PubMedCrossRefGoogle Scholar
  53. 53.
    Bacciu A, Mercante G, Ingegnoli A, et al.: Effects of gastroesophageal reflux disease in laryngeal carcinoma. Clin Otolaryngol 2004, 29:545–548.PubMedCrossRefGoogle Scholar
  54. 54.
    Robertson MS, Hornibrook J: The presenting symptoms of head and neck cancer. N Z Med J 1982, 95:337–341.PubMedGoogle Scholar
  55. 55.
    Pugliano FA, Piccirillo JF, Zequeira MR, et al.: Symptoms as an index of biologic behavior in head and neck cancer. Otolaryngol Head Neck Surg 1999, 120:380–386.PubMedCrossRefGoogle Scholar
  56. 56.
    Dhooge IJ, Albers FW, van Cauwenberge PB: Clinical characteristics and diagnostic delay of head and neck cancer: results from a prospective study in Belgium. Eur J Surg Oncol 1996, 22:354–358.PubMedCrossRefGoogle Scholar
  57. 57.
    Kowalski LP, Carvalho AL: Influence of time delay and clinical upstaging in the prognosis of head and neck cancer. Oral Oncology 2001, 37:94–98.PubMedCrossRefGoogle Scholar
  58. 58.
    Sciubba JJ: Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group. J Am Dent Assoc 1999, 130:1445–1457.PubMedGoogle Scholar
  59. 59.
    Poate TW, Buchanan JA, Hodgson TA, et al.: An audit of the efficacy of the oral brush biopsy technique in a specialist oral mMedicine unit. Oral Oncol 2004, 40:829–834.PubMedCrossRefGoogle Scholar
  60. 60.
    Remmerbach TW, Weidenbach H, Hemprich A, Bocking A: Earliest detection of oral cancer using non-invasive brush biopsy including DNA-image-cytometry: report on four cases. Anal Cell Pathol 2003, 25:159–166.PubMedGoogle Scholar
  61. 61.
    Shillis JA, Hall BA, Sneden GG, Gottlieb NH: Keeping the focus on public health: the struggles of a tobacco prevention task force. Health Educ Behav 2003, 30:771–788.PubMedCrossRefGoogle Scholar
  62. 62.
    Tauras JA: Public policy and smoking cessation among young adults in the United States. Health Policy 2004, 68:321–332.PubMedCrossRefGoogle Scholar
  63. 63.
    Pierce JP, Gilpin EA: News media coverage of smoking and health is associated with changes in population rates of smoking cessation but not initiation. Tob Control 2001, 10:145–153.PubMedCrossRefGoogle Scholar
  64. 64.
    Burkey BB, Day TA: Head and neck cancer screening: results of a multi-institutional effort. Presented at Fifth International Conference on Head and Neck Cancer, San Francisco; 2000.Google Scholar
  65. 65.
    Ramadas K, Sankaranarayanan R, Jacob BJ, et al.: Interim results from a cluster randomized controlled oral cancer screening trial in Kerala, India. Oral Oncol 2003, 39:580–588.PubMedCrossRefGoogle Scholar
  66. 66.
    US Preventive Services Task Force: Screening for Oral Cancer: Brief Evidence Update. Rockville, MD: Agency for Healthcare Research and Quality; 2004. This update from recommendations initially developed in 1996 prepares the researcher in evidence related to approaches to prevention and early detection of oral cancer through screening. 67. American Cancer Society. Oral Cancer. http:///www.cancer.org/ docroot/PRO/content/PRO_1_x_Oral_Cancer.pdf.asp?sitearea=PRO 68. The Canadian Task Force on Preventive Health Care: Screening for Oral Cancer. http://www.ctfphc.org 69. Day TA, Reed SG, Cannick GF, Horowitz AM: Survey of oral and head and neck cancer knowledge among the American public. Presented at the Sixth International Conference on Head and Neck Cancer. Washington, DC; 2004.Google Scholar
  67. 70.
    Horowitz AM, Nourjah P, Gift HC: U.S. adult knowledge of risk factors and signs of oral cancers: 1990. J Am Dent Assoc 1995, 126:39–45.PubMedGoogle Scholar
  68. 71.
    Canto MT, Kawaguchi Y, Horowitz AM: Coverage and quality of oral cancer information in the popular press: 1987–98. J Public Health Dent 1998, 58:241–247.PubMedCrossRefGoogle Scholar
  69. 72.
    WebWhispers. http://webwhispers.org/ Support for People with Oral, Head and Neck Cancer. http://www.spohnc.org/ 2004.Google Scholar
  70. 73.
    The Yul Brynner Head and Neck Cancer Foundation. http://www.headandneck.org/ 2004.Google Scholar
  71. 74.
    The Oral Cancer Foundation. http://www.oralcancerfoundation.org/ 2004.Google Scholar
  72. 75.
    Horowitz AM, Siriphant P, Canto MT, et al.: Maryland dental hygienists’ views of oral cancer prevention and early detection. J Dent Hyg 2002, 76:186–191.PubMedGoogle Scholar
  73. 76.
    Yellowitz JA, Horowitz AM, Drury TF, Goodman HS: Survey of U.S. dentists’ knowledge and opinions about oral pharyngeal cancer. J Am Dent Assoc 2000, 131:653–661.PubMedGoogle Scholar
  74. 77.
    Ahluwalia KP, Yellowitz JA, Goodman HS, Horowitz AM: An assessment of oral cancer prevention curricula in U.S. medical schools. J Cancer Educ 1998, 13:90–95.PubMedGoogle Scholar
  75. 78.
    Baysac MA, Horowitz AM, Ma DS: Oral cancer information in health education textbooks. J Cancer Educ 2004, 19:12–16.PubMedCrossRefGoogle Scholar
  76. 79.
    Papadimitrakopoulou VA: Carcinogenesis of head and neck cancer and the role of chemoprevention in its reversal. Curr Opin Oncol 2000, 12:240–245. An excellent overview of the molecular carcinogenesis of head and neck cancers with an emphasis on chemoprevention in this disease.PubMedCrossRefGoogle Scholar
  77. 80.
    Papadimitrakopoulou VA, Clayman GL, Shin DM, et al.: Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg 1999, 125:1083–1089.PubMedGoogle Scholar
  78. 81.
    Papadimitrakopoulou VA, Liu DD, Mao L, et al.: Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions. Cancer Epidemiol Biomarkers Prev 2002, 11:1605–1610.PubMedGoogle Scholar
  79. 82.
    Toma S, Bonelli L, Sartoris A, et al.: 13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group. Oncol Rep 2004, 11:1297–1305.PubMedGoogle Scholar
  80. 83.
    Benner SE, Pajak TF, Lippman SM, et al.: Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J Natl Cancer Inst 1994, 86:140–141.PubMedCrossRefGoogle Scholar
  81. 84.
    Tsao AS, Kim ES, Hong WK: Chemoprevention of cancer. CA Cancer J Clin 2004, 54:150–180. Although this article covers many cancers amenable to chemopreventive agents, it is particularly useful to those treating head and neck cancer because there is a significant correlation with head and neck cancer chemoprevention and other cancers. Additionally, the article provides an excellent overview of previous trials addressing various agents in head and neck cancer.PubMedCrossRefGoogle Scholar
  82. 85.
    Khuri FR, Kim ES, Lee JJ, et al.: The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev 2001, 10:823–829.PubMedGoogle Scholar
  83. 86.
    Shin DM, Khuri FR, Murphy B, et al.: Combined interferonalfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. J Clin Oncol 2001, 19:3010–3017.PubMedGoogle Scholar
  84. 87.
    Boyle JO: Cyclooxygenase inhibition as a target for prevention of tobacco-related cancers. Clin Cancer Res 2004, 10:1557–1558.PubMedCrossRefGoogle Scholar
  85. 88.
    Gallo O, Franchi A, Magnelli L, et al.: Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer: implications for tumor angiogenesis and metastasis. Neoplasia 2001, 3:53–61.PubMedCrossRefGoogle Scholar
  86. 89.
    Nathan CA, Leskov IL, Lin M, et al.: COX-2 expression in dysplasia of the head and neck: correlation with elF4E. Cancer 2001, 92:1888–1895.PubMedCrossRefGoogle Scholar
  87. 90.
    Antonadou D, Pepelassi M, Synodinou M, et al.: Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002, 52:739–747.PubMedCrossRefGoogle Scholar
  88. 91.
    Hamlar DD, Schuller DE, Gahbauer RA, et al.: Determination of the efficacy of topical oral pilocarpine for postirradiation xerostomia in patients with head and neck carcinoma. Laryngoscope 1996, 106:972–976.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2005

Authors and Affiliations

  • Terry A. Day
    • 1
  • Angela Chi
    • 1
  • Brad Neville
    • 1
  • James R. Hebert
    • 1
  1. 1.Head and Neck Tumor Program, Hollings Cancer CenterMedical University of South CarolinaCharlestonUSA

Personalised recommendations